Published February 27, 2009, 04:50 PM
FDA calls Glaxo ad for prostate drug Avodart misleading
A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The British drugmaker’s Avodart capsules treat symptoms of enlarged prostate, including frequent urination.By: By Matthew Perrone, Associated Press
RSS Feeds